4G/4G Genotype of PAI-1 Gene Is Associated With Reduced Risk of Stroke in Elderly
Author(s) -
Tiny Hoekstra,
Johanna M. Geleijnse,
Cornelis Kluft,
Erik J. Giltay,
Frans J. Kok,
Evert G. Schouten
Publication year - 2003
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.0000098004.26252.eb
Subject(s) - medicine , stroke (engine) , genotype , relative risk , myocardial infarction , fibrinolysis , allele , plasminogen activator inhibitor 1 , population , plasminogen activator , gastroenterology , confidence interval , gene , genetics , engineering , mechanical engineering , biology , environmental health
Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease. The 4G/5G polymorphism affects PAI-1 gene transcription with lower levels of plasma PAI-1 in the presence of the 5G allele. We investigated whether plasma PAI-1 and 4G/5G genotype would predict the occurrence of cardiovascular events at old age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom